These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 239123)

  • 61. Diurnal variations in the motor activity of the rat: effects of inhibitors of the catecholamine synthesis.
    Lemmer B; Berger T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):251-6. PubMed ID: 567282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pituitary follicle-stimulating hormone activity in rats treated with apomorphine, pimozide and drugs that modify catecholamine levels.
    Choudhury SA; Sharpe RM; Brown PS
    Neuroendocrinology; 1973; 12(4):272-83. PubMed ID: 4731030
    [No Abstract]   [Full Text] [Related]  

  • 63. Histochemical studies on the release of the adrenergic transmitter by nerve impulses in combination with drugs, especially adrenergic neuron blocking agents.
    Malmfors T
    Pharmacology; 1969; 2(3):138-50. PubMed ID: 4310294
    [No Abstract]   [Full Text] [Related]  

  • 64. Failure of phenoxybenzamine and pimozide to diminish changes in oxygen consumption and body temperature produced by caffeine.
    Estler CJ
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):326-30. PubMed ID: 485730
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Inhibition of stimulatory effect of methamphetamine and morphine in mice by the modification of endogenous catecholamines].
    Strubelt O; Vogelberg W; Zetler G
    Arzneimittelforschung; 1970 Jan; 20(1):32-7. PubMed ID: 4392499
    [No Abstract]   [Full Text] [Related]  

  • 66. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine.
    Andén NE; Jackson DM
    J Pharm Pharmacol; 1975 Sep; 27(9):666-70. PubMed ID: 241810
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Hamberger B; Malmfors T; Sachs C
    Eur J Pharmacol; 1969 Oct; 8(1):58-72. PubMed ID: 5357075
    [No Abstract]   [Full Text] [Related]  

  • 69. Some pharmacological actions of 2,5-dimethoxy-4-ethylamphetamine (DOET) in rats and mice.
    Huang J; Ho BT
    J Pharm Pharmacol; 1975 Jan; 27(1):18-22. PubMed ID: 235610
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The possible central stimulant mechanisms of some appetite suppressants.
    Offermeier J; Potgieter B
    S Afr Med J; 1972 Jan; 46(4):72-7. PubMed ID: 5058666
    [No Abstract]   [Full Text] [Related]  

  • 71. Long lasting stimulation of locomotor activity produced by the intraventricular injection of a cyclic analogue of dopamine into conscious mice.
    Woodruff GN; Elkhawad AO; Pinder RM
    Eur J Pharmacol; 1974 Jan; 25(1):880-6. PubMed ID: 4154849
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of - and -adrenergic blocking agents and para-chlorophenylalanine on morphine- and caffeine-stimulated locomotor activity of mice.
    Estler CJ
    Psychopharmacologia; 1973; 28(3):261-8. PubMed ID: 4144146
    [No Abstract]   [Full Text] [Related]  

  • 73. Influence of norepinephrine and catecholamine-depleting agents on the synthesis and release of prolactin and growth hormone.
    MacLeod RM
    Endocrinology; 1969 Nov; 85(5):916-23. PubMed ID: 5818077
    [No Abstract]   [Full Text] [Related]  

  • 74. Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylase.
    Dolphin A; Jenner P; Marsden CD
    Eur J Pharmacol; 1976 Jan; 35(1):135-44. PubMed ID: 1253815
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hypertensive effect of dopamine in anesthetized rat.
    Grabowska M
    Pol J Pharmacol Pharm; 1974; 26(3):317-23. PubMed ID: 4852329
    [No Abstract]   [Full Text] [Related]  

  • 76. Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963.
    Lassen JB; Squires RF
    Neuropharmacology; 1976 Nov; 15(11):665-8. PubMed ID: 137365
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacology of beta-(3,4-dimethoxyphenyl)ethyl amine: lack of peripheral and central antidopaminergic properties.
    Jarboe CH; Bannon MJ; Lipson SF
    J Pharm Pharmacol; 1978 Jul; 30(7):450-1. PubMed ID: 27614
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacogenetics of phenylethylamine: determination of heritability and genetic transmission of locomotor effects in recombinant inbred strains of mice.
    Jeste DV; Stoff DM; Rawlings R; Wyatt RJ
    Psychopharmacology (Berl); 1984; 84(4):537-40. PubMed ID: 6441954
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of dopamine on strychnine-induced seizures in the domestic fowl (Gallus domesticus).
    Wambebe C; Osuide G
    Gen Pharmacol; 1983; 14(2):295-7. PubMed ID: 6840513
    [No Abstract]   [Full Text] [Related]  

  • 80. Inhibition of anticholinergic drug-induced locomotor stimulation in mice by alpha-methyltyrosine.
    Thornburg JE; Moore KE
    Neuropharmacology; 1973 Dec; 12(12):1179-85. PubMed ID: 4782696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.